Furthermore, rottlerin inhibited PI3K (phosphoinositide 3-kinase)/Akt/mTOR (mammalian target of rapamycin) pathway, leading to autophagy and apoptosis in pancreatic cancer stem cells [33] and prostate cancer cells [34]. This evidence concerns the gene MTOR and prostate carcinoma.